Technical Analysis for ABT - Abbott Laboratories

Grade Last Price % Change Price Change
C 117.085 0.93% 1.08
ABT closed down 2.66 percent on Thursday, March 4, 2021, on 1.37 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical ABT trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.28%
Expansion Pivot Sell Setup Bearish Swing Setup 0.28%
Stochastic Reached Oversold Weakness 0.28%
Below Lower BB Weakness 0.28%
Lower Bollinger Band Touch Weakness 0.28%
Oversold Stochastic Weakness 0.28%
Multiple of Ten Bearish Other -2.38%
Oversold Stochastic Weakness -2.38%
NR7 Range Contraction -5.05%
Oversold Stochastic Weakness -5.05%
Older End-of-Day Signals for ABT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above 50 DMA 12 minutes ago
60 Minute Opening Range Breakdown about 4 hours ago
Down 1% about 4 hours ago
Rose Above Lower Bollinger Band about 5 hours ago
50 DMA Resistance about 5 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Abbott Laboratories Description

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.


Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Cancer Life Sciences Eye Pain Infectious Diseases Diabetes Pharmaceutical Products Inflammation Hypertension Hematology Influenza Symptoms Lab Testing Lipid Spas Thyroid Glucose Diagnostic Products Fertility Health Care Products Immunoassay Generic Pharmaceutical Influenza Vaccine Nutritional Products Cataract Fever Irritable Bowel Syndrome Blood Glucose Monitoring Contact Lens Dyslipidemia Influenza Vaccines Vascular Products Data Management Software Generic Pharmaceuticals Cataract Surgery Diagnostic Systems Lasik Vascular Disease Cholestasis Hypothyroidism Infectious Agents Intrahepatic Cholestasis Lens Care Products

Is ABT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 128.53
52 Week Low 61.61
Average Volume 4,430,466
200-Day Moving Average 105.68
50-Day Moving Average 116.77
20-Day Moving Average 123.23
10-Day Moving Average 121.01
Average True Range 2.78
ADX 23.16
+DI 14.66
-DI 30.81
Chandelier Exit (Long, 3 ATRs ) 120.20
Chandelier Exit (Short, 3 ATRs ) 123.07
Upper Bollinger Band 129.49
Lower Bollinger Band 116.96
Percent B (%b) -0.08
BandWidth 10.16
MACD Line 0.45
MACD Signal Line 1.69
MACD Histogram -1.2337
Fundamentals Value
Market Cap 205.61 Billion
Num Shares 1.77 Billion
EPS 1.89
Price-to-Earnings (P/E) Ratio 61.35
Price-to-Sales 5.95
Price-to-Book 6.07
PEG Ratio 3.38
Dividend 1.44
Dividend Yield 1.24%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 123.62
Resistance 3 (R3) 124.04 121.92 122.35
Resistance 2 (R2) 121.92 119.99 121.71 121.92
Resistance 1 (R1) 118.97 118.79 117.91 118.55 121.50
Pivot Point 116.85 116.85 116.33 116.64 116.85
Support 1 (S1) 113.90 114.92 112.84 113.48 110.52
Support 2 (S2) 111.78 113.72 111.57 110.10
Support 3 (S3) 108.83 111.78 109.67
Support 4 (S4) 108.41